CLINICAL_TRIALS
trial_result
· 2011-08-11
Clinical Trial Update: Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation [Phase 4]
Summary
A Phase 4 study investigating heme oxygenase activity and adenosine-induced vasodilation in atherosclerotic cardiovascular disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Radboud University Medical Center | Conditions: Atherosclerotic Cardiovascular Disease | Phase 4 | Status: TERMINATED